Latest Stories
Progyny’s (NASDAQ:PGNY) Q4 CY2025: Beats On Revenue
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $318.4 million. On the other hand, next quarter’s revenue guidance of $325.5 million was less impressive, coming in 5.1% below analysts’ estimates. Its non-GAAP profit of $0.48 per share was 19.9% above analysts’ consensus estimates.
American Woodmark (NASDAQ:AMWD) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Cabinet manufacturing company American Woodmark (NASDAQ:AMWD) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 18.4% year on year to $324.3 million. Its non-GAAP profit of $0.45 per share was significantly above analysts’ consensus estimates.
DocuSign, MongoDB, Workiva, Elastic, and PagerDuty Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after Nvidia CEO Jensen Huang dismissed fears that artificial intelligence would cannibalize the enterprise software sector.